Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 3Genitourinary 3Gastrointestinal 3Thoracic 2Other hematologic neoplasm 2Head & Neck 2Breast 1

Conditions

Breast Neoplasms 39Breast Carcinoma In Situ 5Carcinoma, Intraductal, Noninfiltrating 4Rectal Neoplasms 3Ovarian Neoplasms 3Motor Activity 3Endometrial Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Body Weight Changes 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Obesity 2Hereditary Breast and Ovarian Cancer Syndrome 2Depression 2Carcinoma, Renal Cell 2Behavior 2Anxiety Disorders 2Testicular Neoplasms 1Stomach Neoplasms 1Sexuality 1Risk Reduction Behavior 1Penile Neoplasms 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1Pain 1No Evidence of Disease 1Neoplasms 1Kidney Neoplasms 1Health Behavior 1

Interventions

pembrolizumab 9Cyclophosphamide 6fludarabine phosphate 4aldesleukin 3Radiotherapy 3Gemcitabine 3Drug Therapy 3Docetaxel 3Cetuximab 3temsirolimus 2sargramostim 2motexafin gadolinium 2liposomal doxorubicin 2fludarabine 2entinostat 2durvalumab 2belinostat 2atezolizumab 2Sirolimus 2Paclitaxel 2Methods 2Metformin 2Irinotecan 2Interferon-alpha 2Bortezomib 23-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 2valspodar 1tremelimumab 1tocilizumab 1tanespimycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Counseling × Breast × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡